Oxford, UK - August 2009
InhibOx today appointed Paul Davie to drive the next phase of commercial development of the company.
Paul, who studied Chemistry at Oxford University and then the Max-Planck-Gessellschaft in Berlin, has a 25-year track record of success in senior roles in the computer-aided computational chemistry sector. He spent eight years at Chemical Design Ltd before joining Oxford Molecular where he built and managed their commercial operations across Europe. He went on to serve as European General Manager for Accelrys and Chief Operating Officer at Inforsense. He subsequently became the founding CEO at Secerno, the successful database security firm, before returning to the life sciences sector.
